-
1
-
-
0034713820
-
Left ventricular hypertrophy: Pathogenesis, detection, and prognosis
-
Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation. 2000;102:470-479.
-
(2000)
Circulation
, vol.102
, pp. 470-479
-
-
Lorell, B.H.1
Carabello, B.A.2
-
2
-
-
0346098139
-
Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: Altered expression of apoptotic and cytoskeletal genes
-
Yung CK, Halperin VL, Tomaselli GF, Winslow RL. Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. Genomics. 2004;83:281-297.
-
(2004)
Genomics
, vol.83
, pp. 281-297
-
-
Yung, C.K.1
Halperin, V.L.2
Tomaselli, G.F.3
Winslow, R.L.4
-
3
-
-
0027751949
-
Assessing the burden of mortality from cardiovascular diseases
-
Lopez AD. Assessing the burden of mortality from cardiovascular diseases. World Health Stat Q. 1993;46(2):91-96.
-
(1993)
World Health Stat Q
, vol.46
, Issue.2
, pp. 91-96
-
-
Lopez, A.D.1
-
4
-
-
53249090182
-
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
-
Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29(19):2388-2442.
-
(2008)
Eur Heart J
, vol.29
, Issue.19
, pp. 2388-2442
-
-
Dickstein, K.1
Cohen-Solal, A.2
Filippatos, G.3
-
5
-
-
0025266820
-
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications
-
Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81(4):1161-1172.
-
(1990)
Circulation
, vol.81
, Issue.4
, pp. 1161-1172
-
-
Pfeffer, M.A.1
Braunwald, E.2
-
6
-
-
0031907281
-
Pathological versus physiological left ventricular hypertrophy: A review
-
Richey PA, Brown SP. Pathological versus physiological left ventricular hypertrophy: a review. J Sports Sci. 2001;16(2):129-141.
-
(2001)
J Sports Sci
, vol.16
, Issue.2
, pp. 129-141
-
-
Richey, P.A.1
Brown, S.P.2
-
7
-
-
33644878001
-
Risk factors associated with myocardial infarction in Africa: The INTERHEART Africa study
-
Steyn K, Sliwa K, Hawken S, et al; INTERHEART Investigators in Africa. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation. 2005;112(23):3554-3561.
-
(2005)
Circulation
, vol.112
, Issue.23
, pp. 3554-3561
-
-
Steyn, K.1
Sliwa, K.2
Hawken, S.3
INTERHEART Investigators in Africa4
-
8
-
-
44949240325
-
Mortality and the Global Burden of Disease
-
18th ed. New York: McGraw Hill
-
Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J. Mortality and the Global Burden of Disease. Harrison's Principles of Internal Medicine. 18th ed. New York: McGraw Hill; 2012.
-
(2012)
Harrison's Principles of Internal Medicine
-
-
Longo, D.L.1
Kasper, D.L.2
Jameson, J.L.3
Fauci, A.S.4
Hauser, S.L.5
Loscalzo, J.6
-
9
-
-
33746214582
-
Global changes in gene expression during cardiac hypertrophy: A new direction of cardiac signaling research
-
Usui S, Yeh I, Tian B, Sadoshima J. Global changes in gene expression during cardiac hypertrophy: a new direction of cardiac signaling research. J Mol Cell Cardiol. 2006;41(2):219-222.
-
(2006)
J Mol Cell Cardiol
, vol.41
, Issue.2
, pp. 219-222
-
-
Usui, S.1
Yeh, I.2
Tian, B.3
Sadoshima, J.4
-
10
-
-
34547449687
-
Involvement of transient receptor potential proteins in cardiac hypertrophy
-
Guinamard R, Bois P. Involvement of transient receptor potential proteins in cardiac hypertrophy. Biochim Biophys Acta. 2007;1172(8):885-894.
-
(2007)
Biochim Biophys Acta
, vol.1172
, Issue.8
, pp. 885-894
-
-
Guinamard, R.1
Bois, P.2
-
11
-
-
34249904441
-
The acute phase protein alpha2-macroglobulin induces rat ventricular cardiomyocyte hypertrophy via ERK1,2 and PI3-kinase/Akt pathways
-
Padmasekar M, Nandiqama R, Wartenberq M, Schluter KD, Sauer H. The acute phase protein alpha2-macroglobulin induces rat ventricular cardiomyocyte hypertrophy via ERK1,2 and PI3-kinase/Akt pathways. Cardiovasc Res. 2007;75(1):118-128.
-
(2007)
Cardiovasc Res
, vol.75
, Issue.1
, pp. 118-128
-
-
Padmasekar, M.1
Nandiqama, R.2
Wartenberq, M.3
Schluter, K.D.4
Sauer, H.5
-
12
-
-
34548392339
-
Role of diacylglycerol kinase in cellular regulatory processes: A new regulator for cardiomyocyte hypertrophy
-
Takeishi Y, Goto K, Kubota I. Role of diacylglycerol kinase in cellular regulatory processes: a new regulator for cardiomyocyte hypertrophy. Pharmacol Ther. 2007;115(3):352-359.
-
(2007)
Pharmacol Ther
, vol.115
, Issue.3
, pp. 352-359
-
-
Takeishi, Y.1
Goto, K.2
Kubota, I.3
-
13
-
-
37849023059
-
Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice
-
Boengler K, Buechert A, Heinen Y, et al. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res. 2008;102:131-135.
-
(2008)
Circ Res
, vol.102
, pp. 131-135
-
-
Boengler, K.1
Buechert, A.2
Heinen, Y.3
-
14
-
-
3342889421
-
Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury
-
Hilfiker-Kleiner D, Hilfiker A, Fuchs M, et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res. 2004;95:187-195.
-
(2004)
Circ Res
, vol.95
, pp. 187-195
-
-
Hilfiker-Kleiner, D.1
Hilfiker, A.2
Fuchs, M.3
-
16
-
-
42949120754
-
Identification of novel direct Stat3 target genes for control of growth and differentiation
-
Snyder M, Huang XY, Zhang JJL. Identification of novel direct Stat3 target genes for control of growth and differentiation. J Biol Chem. 2008;283:3791-3798.
-
(2008)
J Biol Chem
, vol.283
, pp. 3791-3798
-
-
Snyder, M.1
Huang, X.Y.2
Zhang, J.J.L.3
-
17
-
-
34250315274
-
Survival pathways in hypertrophy and heart failure: The gp130-STAT3 axis
-
Fischer P, Hilfiker-Kleiner D. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis. Basic Res Cardiol. 2007;102:279-297.
-
(2007)
Basic Res Cardiol
, vol.102
, pp. 279-297
-
-
Fischer, P.1
Hilfiker-Kleiner, D.2
-
18
-
-
0036852779
-
Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: Role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure
-
Booz GW, Day JNE, Baker KM. Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. J Mol Cell Cardiol. 2002;34:1443-1453.
-
(2002)
J Mol Cell Cardiol
, vol.34
, pp. 1443-1453
-
-
Booz, G.W.1
Day, J.N.E.2
Baker, K.M.3
-
19
-
-
33747338922
-
JAK/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart
-
Terrell AM, Crisostomo PR, Wairiuko GM, Wang M, Morrell ED, Meldrum DR. JAK/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart. Shock. 2006;26:226-234.
-
(2006)
Shock
, vol.26
, pp. 226-234
-
-
Terrell, A.M.1
Crisostomo, P.R.2
Wairiuko, G.M.3
Wang, M.4
Morrell, E.D.5
Meldrum, D.R.6
-
20
-
-
44049091020
-
Clinical efficacy and safety of statins in managing cardiovascular risk
-
Kapur NK, Musunuru K. Clinical efficacy and safety of statins in managing cardiovascular risk. Vasc Health Risk Manag. 2008;4:341-453.
-
(2008)
Vasc Health Risk Manag
, vol.4
, pp. 341-453
-
-
Kapur, N.K.1
Musunuru, K.2
-
21
-
-
83755220049
-
Interplay between statins and PPARs in improving cardiovascular outcomes: A double-edged sword?
-
Balakumar P, Mahadevan N. Interplay between statins and PPARs in improving cardiovascular outcomes: a double-edged sword? Br J Pharmacol. 2012;165:373-379.
-
(2012)
Br J Pharmacol
, vol.165
, pp. 373-379
-
-
Balakumar, P.1
Mahadevan, N.2
-
22
-
-
33645223846
-
Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction
-
Iwakura K, Ito H, Kawano S, et al. Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction. Eur Heart J. 2006;27(5):534-539.
-
(2006)
Eur Heart J
, vol.27
, Issue.5
, pp. 534-539
-
-
Iwakura, K.1
Ito, H.2
Kawano, S.3
-
23
-
-
33748995111
-
Pretreatment with simvastatin reduces myocardial no-reflow by opening mitochondrial K(ATP) channel
-
Zhao JL, Yang YJ, Cui CJ, You SJ, Gao RL. Pretreatment with simvastatin reduces myocardial no-reflow by opening mitochondrial K(ATP) channel. Br J Pharmacol. 2006;149(3):243-249.
-
(2006)
Br J Pharmacol
, vol.149
, Issue.3
, pp. 243-249
-
-
Zhao, J.L.1
Yang, Y.J.2
Cui, C.J.3
You, S.J.4
Gao, R.L.5
-
24
-
-
35348975175
-
The cardioprotective effect of a statin and cilostazol combination: Relationship to Akt and endothelial nitric oxide synthase activation
-
Manickavasagam S, Ye Y, Lin Y, et al. The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation. Cardiovasc Drugs Ther. 2007;21(5):321-330.
-
(2007)
Cardiovasc Drugs Ther
, vol.21
, Issue.5
, pp. 321-330
-
-
Manickavasagam, S.1
Ye, Y.2
Lin, Y.3
-
25
-
-
34548421559
-
The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation
-
Merla R, Ye Y, Lin Y, et al. The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation. Am J Physiol Heart Circ Physiol. 2007;293(3):H1918-H1928.
-
(2007)
Am J Physiol Heart Circ Physiol
, vol.293
, Issue.3
, pp. H1918-H1928
-
-
Merla, R.1
Ye, Y.2
Lin, Y.3
-
26
-
-
0035141474
-
Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyocytes
-
Luo JD, Xie F, Zhang WW, Ma XD, Guan JX, Chen X. Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyocytes. Br J Pharmacol. 2001;132(1):159-164.
-
(2001)
Br J Pharmacol
, vol.132
, Issue.1
, pp. 159-164
-
-
Luo, J.D.1
Xie, F.2
Zhang, W.W.3
Ma, X.D.4
Guan, J.X.5
Chen, X.6
-
27
-
-
33745894649
-
Simvastatin attenuates hypertrophic responses induced by cardiotrophin-1 via JAK-STAT pathway in cultured cardiomyocytes
-
Wu L, Zhao L, Zheng Q, et al. Simvastatin attenuates hypertrophic responses induced by cardiotrophin-1 via JAK-STAT pathway in cultured cardiomyocytes. Mol Cell Biochem. 2006;284(1-2):65-71.
-
(2006)
Mol Cell Biochem
, vol.284
, Issue.1-2
, pp. 65-71
-
-
Wu, L.1
Zhao, L.2
Zheng, Q.3
-
28
-
-
42649089174
-
Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway
-
Liu J, Shen Q, Wu Y. Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway. Life Sci. 2008;82:991-996.
-
(2008)
Life Sci
, vol.82
, pp. 991-996
-
-
Liu, J.1
Shen, Q.2
Wu, Y.3
-
29
-
-
0016373654
-
Enzymatic determination of total serum cholesterol
-
Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20(4):470-475.
-
(1974)
Clin Chem
, vol.20
, Issue.4
, pp. 470-475
-
-
Allain, C.C.1
Poon, L.S.2
Chan, C.S.3
Richmond, W.4
Fu, P.C.5
-
30
-
-
0019949179
-
Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide
-
Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28(1):2077-2080.
-
(1982)
Clin Chem
, vol.28
, Issue.1
, pp. 2077-2080
-
-
Fossati, P.1
Prencipe, L.2
-
31
-
-
0014876627
-
Rapid method for isolation of lipoprotein from human serum with polyanions
-
Burnstein M, Selvenick HR, Morfin R. Rapid method for isolation of lipoprotein from human serum with polyanions. J Lipid Res. 1970;11:583-595.
-
(1970)
J Lipid Res
, vol.11
, pp. 583-595
-
-
Burnstein, M.1
Selvenick, H.R.2
Morfin, R.3
-
33
-
-
0015348189
-
Estimation of concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge
-
Friedewald WT. Estimation of concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18(7):499-502.
-
(1972)
Clin Chem
, vol.18
, Issue.7
, pp. 499-502
-
-
Friedewald, W.T.1
-
34
-
-
0002397219
-
The pathogenesis of atherosclerosis
-
Braunwald E, editor, 4th ed. Philadelphia, PA: W. B. Saunders Company
-
Ross R. The pathogenesis of atherosclerosis. In: Braunwald E, editor. Heart Disease. 4th ed. Philadelphia, PA: W. B. Saunders Company; 1992;1106-1124.
-
(1992)
Heart Disease
, pp. 1106-1124
-
-
Ross, R.1
-
35
-
-
33846857559
-
Heart disease and stroke statistics - 2007 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
-
Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics - 2007 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69-e171.
-
(2007)
Circulation
, vol.115
, pp. e69-e171
-
-
Rosamond, W.1
Flegal, K.2
Friday, G.3
-
36
-
-
77951152823
-
Myoglobin-deficient mice activate a distinct cardiac gene expression program in response to isoproterenol-induced hypertrophy
-
Molojavyi A, Lindecke A, Raupach A, Moellendorf S, Köhrer K, Gödecke A. Myoglobin-deficient mice activate a distinct cardiac gene expression program in response to isoproterenol-induced hypertrophy. Physiol Genomics. 2010;41:137-145.
-
(2010)
Physiol Genomics
, vol.41
, pp. 137-145
-
-
Molojavyi, A.1
Lindecke, A.2
Raupach, A.3
Moellendorf, S.4
Köhrer, K.5
Gödecke, A.6
-
37
-
-
0038795603
-
Regression of isoproterenol-induced cardiac hypertrophy by Na+/H+ exchanger inhibition
-
Ennis IL, Escudero EM, Console GM, et al. Regression of isoproterenol-induced cardiac hypertrophy by Na+/H+ exchanger inhibition. Hypertension. 2003;41:1324-1329.
-
(2003)
Hypertension
, vol.41
, pp. 1324-1329
-
-
Ennis, I.L.1
Escudero, E.M.2
Console, G.M.3
-
38
-
-
0037281330
-
Synergistic effect of nicorandil and amlodipine on tissue defense system during experimental myocardial infarction in rats
-
Sathish V, Ebenezar KK, Devaki T. Synergistic effect of nicorandil and amlodipine on tissue defense system during experimental myocardial infarction in rats. Mol Cell Biochem. 2003;243:133-138.
-
(2003)
Mol Cell Biochem
, vol.243
, pp. 133-138
-
-
Sathish, V.1
Ebenezar, K.K.2
Devaki, T.3
-
39
-
-
3142770716
-
Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure
-
Weihua Z, Vijayan E, Mohinder SN, Suresh KG, Naranjan SD. Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure. Exp Clin Cardiol. 2003;8:173-183.
-
(2003)
Exp Clin Cardiol
, vol.8
, pp. 173-183
-
-
Weihua, Z.1
Vijayan, E.2
Mohinder, S.N.3
Suresh, K.G.4
Naranjan, S.D.5
-
40
-
-
0021261142
-
Development of isoproterenol-induced cardiac hypertrophy
-
Taylor PB, Tang Q. Development of isoproterenol-induced cardiac hypertrophy. Can J Physiol Pharmacol. 1984;62:384-389.
-
(1984)
Can J Physiol Pharmacol
, vol.62
, pp. 384-389
-
-
Taylor, P.B.1
Tang, Q.2
-
41
-
-
77955476705
-
Protective effects of Lagenaria siceraria (Molina) fruit juice in isoproterenol induced myocardial infarction
-
Upaganlawar A, Balaraman R. Protective effects of Lagenaria siceraria (Molina) fruit juice in isoproterenol induced myocardial infarction. Int J Pharmacol. 2010;6(5):645-651.
-
(2010)
Int J Pharmacol
, vol.6
, Issue.5
, pp. 645-651
-
-
Upaganlawar, A.1
Balaraman, R.2
-
42
-
-
84876442003
-
Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats
-
Li H, Xie YH, Yang Q, et al. Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats. PLoS One. 2012;7(11):e48872.
-
(2012)
PLoS One
, vol.7
, Issue.11
-
-
Li, H.1
Xie, Y.H.2
Yang, Q.3
-
43
-
-
77955771674
-
Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: A biochemical, electrocardiographic and histoarchitectural evaluation
-
Patel V, Upaganlawar A, Zalawadia R, Balaraman R. Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, electrocardiographic and histoarchitectural evaluation. Eur J Pharmacol. 2010;644:160-168.
-
(2010)
Eur J Pharmacol
, vol.644
, pp. 160-168
-
-
Patel, V.1
Upaganlawar, A.2
Zalawadia, R.3
Balaraman, R.4
-
44
-
-
0013647072
-
Hemodynamics during the chronic stage of myocardial damage caused by isoproterenol
-
Beznak M, Hacker P. Hemodynamics during the chronic stage of myocardial damage caused by isoproterenol. Can J Cardiol. 1964;42:269-274.
-
(1964)
Can J Cardiol
, vol.42
, pp. 269-274
-
-
Beznak, M.1
Hacker, P.2
-
45
-
-
0015880529
-
Hemodynamics in the rat with isoproterenol induced cardiac hypertrophy
-
Lin YC. Hemodynamics in the rat with isoproterenol induced cardiac hypertrophy. Res Commun Chem Pathol Pharmacol. 1973;6:213-220.
-
(1973)
Res Commun Chem Pathol Pharmacol
, vol.6
, pp. 213-220
-
-
Lin, Y.C.1
-
46
-
-
0019956262
-
Exercise capacity and cardiac function of rats with drug-induced cardiac enlargement
-
Baldwin KM, Ernst SB, Mullin WJ, Schrader LF, Herrick RE. Exercise capacity and cardiac function of rats with drug-induced cardiac enlargement. J Appl Physiol. 1982;52:591-595.
-
(1982)
J Appl Physiol
, vol.52
, pp. 591-595
-
-
Baldwin, K.M.1
Ernst, S.B.2
Mullin, W.J.3
Schrader, L.F.4
Herrick, R.E.5
-
47
-
-
0023920657
-
Contractile performance of papillary muscles of renovascular hypertensive and isoproterenol pretreated rats
-
Vassalo DV, Vasquez EC, Cabral AM. Contractile performance of papillary muscles of renovascular hypertensive and isoproterenol pretreated rats. Pharmacol Res Commun. 1988;20:61-72.
-
(1988)
Pharmacol Res Commun
, vol.20
, pp. 61-72
-
-
Vassalo, D.V.1
Vasquez, E.C.2
Cabral, A.M.3
-
48
-
-
0025148815
-
Cardiac inotropic responses to calcium and foskolin are not altered by prolonged isoproterenol infusion
-
Bowling N, Wyss VL, Gengo PJ, Utterback B, Kauffman RF, Hayes IN. Cardiac inotropic responses to calcium and foskolin are not altered by prolonged isoproterenol infusion. Eur J Pharmacol. 1990;187:155-164.
-
(1990)
Eur J Pharmacol
, vol.187
, pp. 155-164
-
-
Bowling, N.1
Wyss, V.L.2
Gengo, P.J.3
Utterback, B.4
Kauffman, R.F.5
Hayes, I.N.6
-
49
-
-
33750813323
-
Relation between contractile function and regulatory cardiac proteins in hypertrophied hearts
-
Stein B, Bartel S, Kirchhefer U, et al. Relation between contractile function and regulatory cardiac proteins in hypertrophied hearts. Am J Physiol. 1996;270:H2021-H2028.
-
(1996)
Am J Physiol
, vol.270
, pp. H2021-H2028
-
-
Stein, B.1
Bartel, S.2
Kirchhefer, U.3
-
50
-
-
0026709230
-
Functional changes in the right and left ventricle during development of cardiac hypertrophy and after its regression
-
Cihák R, Kolar F, Pelouch V, Prochazka J, Ostadal B, Widimsky J. Functional changes in the right and left ventricle during development of cardiac hypertrophy and after its regression. Cardiovasc Res. 1992;26:845-850.
-
(1992)
Cardiovasc Res
, vol.26
, pp. 845-850
-
-
Cihák, R.1
Kolar, F.2
Pelouch, V.3
Prochazka, J.4
Ostadal, B.5
Widimsky, J.6
-
51
-
-
0030727083
-
A calcium stimulated cysteine protease involved in isoproterenol induced cardiac hypertrophy
-
Arthur GD, Belcastro AN. A calcium stimulated cysteine protease involved in isoproterenol induced cardiac hypertrophy. Mol Cell Biochem. 1997;176:241-248.
-
(1997)
Mol Cell Biochem
, vol.176
, pp. 241-248
-
-
Arthur, G.D.1
Belcastro, A.N.2
-
52
-
-
0029893429
-
Altered contractile function in isoproterenol-induced hypertrophied rat heart
-
Tang Q, Taylor PB. Altered contractile function in isoproterenol-induced hypertrophied rat heart. J Hypertens. 1996;14:751-757.
-
(1996)
J Hypertens
, vol.14
, pp. 751-757
-
-
Tang, Q.1
Taylor, P.B.2
-
53
-
-
51049115136
-
Green tea attenuates angiotensin II induced cardiac hypertrophy in rats by modulating reactive oxygen species production and the Src/epidermal growth factor receptor/Akt signaling pathway
-
Papparella I, Ceolotto G, Montemurro D, et al. Green tea attenuates angiotensin II induced cardiac hypertrophy in rats by modulating reactive oxygen species production and the Src/epidermal growth factor receptor/Akt signaling pathway. J Nutr. 2008;138(9):1596-1601.
-
(2008)
J Nutr
, vol.138
, Issue.9
, pp. 1596-1601
-
-
Papparella, I.1
Ceolotto, G.2
Montemurro, D.3
-
54
-
-
27544512189
-
Preventive effect of Aegle marmelos leaf extract on isoprenaline induced myocardial infarction in rats: Biochemical evidence
-
Prince PS, Rajadurai M. Preventive effect of Aegle marmelos leaf extract on isoprenaline induced myocardial infarction in rats: biochemical evidence. J Pharm Pharmacol. 2005;57:1353-1357.
-
(2005)
J Pharm Pharmacol
, vol.57
, pp. 1353-1357
-
-
Prince, P.S.1
Rajadurai, M.2
-
55
-
-
68649091453
-
Simvastatin alleviates myocardial contractile dysfunction and lethal ischemic injury in rat heart independent of cholesterol-lowering effects
-
Adameova A, Harcarova A, Matejikova J, et al. Simvastatin alleviates myocardial contractile dysfunction and lethal ischemic injury in rat heart independent of cholesterol-lowering effects. Physiol Res. 2009;58:449-454.
-
(2009)
Physiol Res
, vol.58
, pp. 449-454
-
-
Adameova, A.1
Harcarova, A.2
Matejikova, J.3
-
56
-
-
33747033675
-
HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1
-
Morikawa-Futamatsu K, Adachi S, Maejima Y, et al. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1. Life Sci. 2006;79(14):1380-1390.
-
(2006)
Life Sci
, vol.79
, Issue.14
, pp. 1380-1390
-
-
Morikawa-Futamatsu, K.1
Adachi, S.2
Maejima, Y.3
-
57
-
-
0035979347
-
Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor
-
Dechend R, Fiebeler A, Park JK, et al. Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor. Circulation. 2001;104(5):576-581.
-
(2001)
Circulation
, vol.104
, Issue.5
, pp. 576-581
-
-
Dechend, R.1
Fiebeler, A.2
Park, J.K.3
-
58
-
-
0033037565
-
Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB
-
Apple FS. Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB. Clin Chim Acta. 1999;284:151-159.
-
(1999)
Clin Chim Acta
, vol.284
, pp. 151-159
-
-
Apple, F.S.1
-
59
-
-
0031977811
-
Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure
-
Tsutamoto T, Hisanaga T, Wada A, et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol. 1998;31:391-398.
-
(1998)
J Am Coll Cardiol
, vol.31
, pp. 391-398
-
-
Tsutamoto, T.1
Hisanaga, T.2
Wada, A.3
-
60
-
-
0342424731
-
Prognostic value of serum cytokines in patients with congestive heart failure
-
Orús J, Roig E, Perez-Villa F, et al. Prognostic value of serum cytokines in patients with congestive heart failure. J Heart Lung Transplant. 2000;19:419-425.
-
(2000)
J Heart Lung Transplant
, vol.19
, pp. 419-425
-
-
Orús, J.1
Roig, E.2
Perez-Villa, F.3
-
61
-
-
0142010515
-
C reactive protein and interleukin-6 in vascular disease: Culprits or passive bystanders?
-
Rattazzi M, Puato M, Faggin E, Bertipaglia B, Zambon A, Pauletto P. C reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? J Hypertens. 2003;21:1787-1803.
-
(2003)
J Hypertens
, vol.21
, pp. 1787-1803
-
-
Rattazzi, M.1
Puato, M.2
Faggin, E.3
Bertipaglia, B.4
Zambon, A.5
Pauletto, P.6
-
62
-
-
16344367552
-
Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: Correlations with serum troponin I
-
Manginas A, Bei E, Chaidaroglou A, et al. Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: correlations with serum troponin I. Clin Cardiol. 2005;28:182-186.
-
(2005)
Clin Cardiol
, vol.28
, pp. 182-186
-
-
Manginas, A.1
Bei, E.2
Chaidaroglou, A.3
-
63
-
-
34249040813
-
Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndrome
-
Shu J, Ren N, Du JB, Zhang M, Cong HL, Huang TG. Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndrome. Scand Cardiovasc J. 2007;41:149-154.
-
(2007)
Scand Cardiovasc J
, vol.41
, pp. 149-154
-
-
Shu, J.1
Ren, N.2
Du, J.B.3
Zhang, M.4
Cong, H.L.5
Huang, T.G.6
-
64
-
-
0028909730
-
Hypoxic stress induces cardiac myocyte-derived interleukin-6
-
Yamauchi-Takihara K, Ihara Y, Ogata A, Yoshizaki K, Azuma J, Kishimoto T. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation. 1995;91:1520-1524.
-
(1995)
Circulation
, vol.91
, pp. 1520-1524
-
-
Yamauchi-Takihara, K.1
Ihara, Y.2
Ogata, A.3
Yoshizaki, K.4
Azuma, J.5
Kishimoto, T.6
-
65
-
-
0028997843
-
Continuous activation of Gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice
-
Hirota H, Yoshida K, Kishimoto T, Taga T. Continuous activation of Gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci U S A. 1995;92:4862-4866.
-
(1995)
Proc Natl Acad Sci U S A
, vol.92
, pp. 4862-4866
-
-
Hirota, H.1
Yoshida, K.2
Kishimoto, T.3
Taga, T.4
-
66
-
-
0033514260
-
Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions
-
Gwechenberger M, Mendoza LH, Youker KA, et al. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation. 1999;99:546-551.
-
(1999)
Circulation
, vol.99
, pp. 546-551
-
-
Gwechenberger, M.1
Mendoza, L.H.2
Youker, K.A.3
-
67
-
-
79251495785
-
Metformin inhibits isoproterenol-induced cardiac hypertrophy in mice
-
Cha HN, Choi JH, Kim YW, Kim JY, Ahn MW, Park SY. Metformin inhibits isoproterenol-induced cardiac hypertrophy in mice. Korean J Physiol Pharmacol. 2010;14:377-384.
-
(2010)
Korean J Physiol Pharmacol
, vol.14
, pp. 377-384
-
-
Cha, H.N.1
Choi, J.H.2
Kim, Y.W.3
Kim, J.Y.4
Ahn, M.W.5
Park, S.Y.6
-
68
-
-
0038393312
-
Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF kappa B in human colorectal cancer
-
Maihçfner C, Charalambous MP, Bhambra U, Lightfoot T, Geisslinger G, Gooderham NJ. Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF kappa B in human colorectal cancer. Carcinogenesis. 2003;24:665-671.
-
(2003)
Carcinogenesis
, vol.24
, pp. 665-671
-
-
Maihçfner, C.1
Charalambous, M.P.2
Bhambra, U.3
Lightfoot, T.4
Geisslinger, G.5
Gooderham, N.J.6
-
69
-
-
4644324186
-
NF-kappaB functions as a tumour promoter in inflammation-associated cancer
-
Pikarsky E, Porat RM, Stein I, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004;431:461-466.
-
(2004)
Nature
, vol.431
, pp. 461-466
-
-
Pikarsky, E.1
Porat, R.M.2
Stein, I.3
-
70
-
-
36749001714
-
Chemopreventive effect of plant originated glycoprotein on colitis-mediated colorectal cancer in A⁄J mice
-
Lee SJ, Lim KT. Chemopreventive effect of plant originated glycoprotein on colitis-mediated colorectal cancer in A⁄J mice. J Biomed Sci. 2008;15:111-121.
-
(2008)
J Biomed Sci
, vol.15
, pp. 111-121
-
-
Lee, S.J.1
Lim, K.T.2
-
71
-
-
84904111086
-
Rapamycin attenuated cardiac hypertrophy induced by isoproterenol and maintained energy homeostasis via inhibiting NF-κB activation
-
Chen X, Zeng S, Zou J, et al. Rapamycin attenuated cardiac hypertrophy induced by isoproterenol and maintained energy homeostasis via inhibiting NF-κB activation. Mediators Inflamm. 2014;2014:868753.
-
(2014)
Mediators Inflamm
, vol.2014
-
-
Chen, X.1
Zeng, S.2
Zou, J.3
-
72
-
-
37449022587
-
Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy
-
Serrano AL, Baeza-Raja B, Perdiguero E, Jardi M, Munoz-Cinoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 2008;7:33-44.
-
(2008)
Cell Metab
, vol.7
, pp. 33-44
-
-
Serrano, A.L.1
Baeza-Raja, B.2
Perdiguero, E.3
Jardi, M.4
Munoz-Cinoves, P.5
-
73
-
-
33847766236
-
Eccentric cardiac hypertrophy was induced by long term intermittent hypoxia in rats
-
Chen LM, Kuo WW, Yang JJ, et al. Eccentric cardiac hypertrophy was induced by long term intermittent hypoxia in rats. Exp Physiol. 2007;92:409-416.
-
(2007)
Exp Physiol
, vol.92
, pp. 409-416
-
-
Chen, L.M.1
Kuo, W.W.2
Yang, J.J.3
-
74
-
-
19944427539
-
STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart
-
Oshima Y, Fujio Y, Nakanishi T, et al. STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart. Cardiovasc Res. 2005;65(2):428-435.
-
(2005)
Cardiovasc Res
, vol.65
, Issue.2
, pp. 428-435
-
-
Oshima, Y.1
Fujio, Y.2
Nakanishi, T.3
-
75
-
-
33846815097
-
Role of the JAK-STAT pathway in myocardial injury
-
Barry SP, Townsend PA, Latchman DS, Stephanou A. Role of the JAK-STAT pathway in myocardial injury. Trends Mol Med. 2007;13(2):82-89.
-
(2007)
Trends Mol Med
, vol.13
, Issue.2
, pp. 82-89
-
-
Barry, S.P.1
Townsend, P.A.2
Latchman, D.S.3
Stephanou, A.4
|